Pure Global AI
Manufacturer profile

AGILENT TECHNOLOGIES, INC.

BrazilUnited States20 ANVISA registrations12 unique technical categoriesDec 26, 2016 – Jul 06, 2026
20
Total products
12
Technical names
Dec 2016
Earliest registration
Jul 2026
Latest registration
Regulatory footprint
Search AGILENT TECHNOLOGIES, INC. across other regulatory registries
Recent registrations
Latest 5 products registered by this manufacturer
Most popular products
Products with most registrations
Top registration holders
Companies holding product registrations for this manufacturer
Top competitors
Companies with the most overlapping products (same technical names)
VENTANA MEDICAL SYSTEM, INC
United States
33 registrations10 shared products
Shared products
COMPANION DIAGNOSTICS, CYTOLOGICAL STAINS, IMMUNOHISTOCHEMISTRY - CARCINOMA MARKERS IN GENERAL, IMMUNOHISTOCHEMISTRY - COMPLEMENTARY REAGENTS, IMMUNOHISTOCHEMISTRY - LYMPHOMA AND LEUKEMIA MARKERS, IMMUNOHISTOCHEMISTRY - MARKERS FOR BREAST CARCINOMAS, IMMUNOHISTOCHEMISTRY - MARKERS FOR GASTROINTESTINAL TRACT CARCINOMAS, IMMUNOHISTOCHEMISTRY - MARKERS FOR SKIN CARCINOMAS AND MELANOMAS, IMMUNOHISTOCHEMISTRY - PROSTATE CARCINOMA MARKERS, TAMPÕES, DILUENTES E DEMAIS SOLUÇÕES PARA ANÁLISE LABORATORIAL
AGILENT TECHNOLOGIES SINGAPORE (INTERNATIONAL) PTE LTD.
Singapore
18 registrations9 shared products
Shared products
COMPANION DIAGNOSTICS, CYTOLOGICAL STAINS, IMMUNOHISTOCHEMISTRY - CARCINOMA MARKERS IN GENERAL, IMMUNOHISTOCHEMISTRY - COMPLEMENTARY REAGENTS, IMMUNOHISTOCHEMISTRY - LYMPHOMA AND LEUKEMIA MARKERS, IMMUNOHISTOCHEMISTRY - MARKERS FOR GASTROINTESTINAL TRACT CARCINOMAS, IMMUNOHISTOCHEMISTRY - MARKERS FOR SKIN CARCINOMAS AND MELANOMAS, IN SITU HYBRIDIZATION - COMPLEMENTARY REAGENTS, TAMPÕES, DILUENTES E DEMAIS SOLUÇÕES PARA ANÁLISE LABORATORIAL
LEICA BIOSYSTEMS NEWCASTLE LTD
United Kingdom
9 registrations9 shared products
Shared products
COMPANION DIAGNOSTICS, IMMUNOHISTOCHEMISTRY - CARCINOMA MARKERS IN GENERAL, IMMUNOHISTOCHEMISTRY - COMPLEMENTARY REAGENTS, IMMUNOHISTOCHEMISTRY - LYMPHOMA AND LEUKEMIA MARKERS, IMMUNOHISTOCHEMISTRY - MARKERS FOR BREAST CARCINOMAS, IMMUNOHISTOCHEMISTRY - MARKERS FOR GASTROINTESTINAL TRACT CARCINOMAS, IMMUNOHISTOCHEMISTRY - MARKERS FOR SKIN CARCINOMAS AND MELANOMAS, IMMUNOHISTOCHEMISTRY - PROSTATE CARCINOMA MARKERS, IN SITU HYBRIDIZATION - COMPLEMENTARY REAGENTS
CELL MARQUE CORPORATION
United States
15 registrations6 shared products
Shared products
IMMUNOHISTOCHEMISTRY - CARCINOMA MARKERS IN GENERAL, IMMUNOHISTOCHEMISTRY - LYMPHOMA AND LEUKEMIA MARKERS, IMMUNOHISTOCHEMISTRY - MARKERS FOR BREAST CARCINOMAS, IMMUNOHISTOCHEMISTRY - MARKERS FOR GASTROINTESTINAL TRACT CARCINOMAS, IMMUNOHISTOCHEMISTRY - MARKERS FOR SKIN CARCINOMAS AND MELANOMAS, IMMUNOHISTOCHEMISTRY - PROSTATE CARCINOMA MARKERS
ROCHE DIAGNOSTICS GMBH
Germany
66 registrations4 shared products
Shared products
COMPANION DIAGNOSTICS, IMMUNOHISTOCHEMISTRY - CARCINOMA MARKERS IN GENERAL, IMMUNOHISTOCHEMISTRY - MARKERS FOR BREAST CARCINOMAS, TAMPÕES, DILUENTES E DEMAIS SOLUÇÕES PARA ANÁLISE LABORATORIAL
About this profile

Explore comprehensive manufacturer profile for AGILENT TECHNOLOGIES, INC. based in United States through Pure Global AI's free Brazil medical device database. This manufacturer has 20 products registered with ANVISA across 12 unique technical categories. Their regulatory history spans from Dec 26, 2016 to Jul 06, 2026.

This page provides detailed insights including 5 recent product registrations including IN SITU HYBRIDIZATION - COMPLEMENTARY REAGENTS, 5 most popular products with IMMUNOHISTOCHEMISTRY - COMPLEMENTARY REAGENTS having 4 registrations, 1 registration holders including AGILENT TECHNOLOGIES BRASIL LTDA, and 5 key competitors with VENTANA MEDICAL SYSTEM, INC sharing 10 products. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, enabling global MedTech companies to analyze market dynamics and identify opportunities.